Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin in high-risk pregnancy identified by abnormal first-trimester uterine artery Doppler
2012-000622-22Phase 2Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Cartia in preeclampsia and placental insufficiency, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Uterine artery mean pulsatility index at 28 weeks. Started May 2012; status: completed.
02
Drugs
Cartia
03
Conditions
preeclampsiaplacental insufficiency
Beyond the preview
Go deeper on 2012-000622-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000622-22.